Search results
Kansas sues Pfizer over COVID vaccine for what Kris Kobach calls 'misleading marketing'
The Topeka Capital-Journal via Yahoo News· 4 days agoThe AG's complaint says that the company advertised that its vaccine was "life-saving" in three ads...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 20 hours agoUsually, RSV causes coldlike symptoms in most people. But in newborns and older adults it can be...
Merck's vaccine approval poses threat to one of Pfizer's top-selling products
Morningstar· 4 days agoMerck & Co. Inc. on Monday gained U.S. regulatory approval for a vaccine that could become a tough competitor to one of Pfizer Inc.'s top-selling products. The Food and Drug ...
CARsgen’s CAR T MM therapy shows early signs of efficacy in Phase I trial
Clinical Trials Arena via Yahoo Finance· 4 days agoInvestigators had dosed ten patients as of the 28 February data cut off, seven at a low dose and ...
Gateway - Quartz
Quartz· 3 days agoThe company announced on Oct. 20 that it intends to sell the covid vaccine, marketed under the brand name Comirnaty, for $110 to $130 per dose. According to The People’s Vaccine ...
Feeling Sick After Your COVID Vaccine? According to Scientists, It’s Actually a Good Sign
SciTechDaily· 2 days agoA UCSF study suggests that side effects like headaches and chills from COVID-19 vaccines indicate a...
Third Rock’s Marea ropes in $190M to pioneer ‘the next frontier’ of cardiometabolic medicines
FierceBiotech· 3 days agoPreclinical models found that MAR001 reduced triglycerides, remnant cholesterol and ectopic fat,...
FDA puts partial clinical hold on BioNTech’s ADC trial after fatalities
Clinical Trials Arena via Yahoo Finance· 3 days agoTo address the FDA... Growth Factor Receptor 3 (HER3). Other big pharma companies including Pfizer,...
Pharma Stock Roundup: FDA Panel Endorses LLY's Donanemab, PFE's DMD Therapy Study Fails -...
Benzinga· 7 days agoPfizer's PFE phase III study of investigational gene therapy, fordadistrogene movaparvovec, for...
Izokibep Enthesitis Benefit Lacking in Phase 2b/3 PsA Trial
Medscape· 2 days agoThe primary efficacy endpoint was met, but the novel small molecule therapeutic did not reduce...